Dr. Maisa A. Nazzal, MD

Dr. Nazzal practices at SSM Health St. Clare Hospital - Fenton in Fenton, Missouri, part of SSM Health Care.

Dr. Nazzal's NPI, 1295991073, was assigned on August 1, 2008. Dr. Nazzal holds Missouri license 2016012961.

Dr. Nazzal's primary practice is SSM Health St. Clare Hospital - Fenton, at 1015 Bowles, Fenton, MO 63026 in Jefferson County. The practice phone is (636) 496-2000.

Dr. Nazzal's primary practice is SSM Health St. Clare Hospital - Fenton in Fenton, Missouri, part of SSM Health Care. Dr. Nazzal is also affiliated with SSM Health Saint Louis University Hospital. The medical group on file is Med Clinical Practice. Dmand AI also links Dr. Nazzal to 2 more hospitals, 3 dialysis centers, 1 physician office, 1 hospital outpatient department and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nazzal practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Nazzal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Nazzal's licenses on file in 4 states: Missouri, Arkansas, Illinois and Oklahoma.

CMS data shows 682 Medicare services from Dr. Nazzal across 5 procedure codes in 2024, for 152 Medicare patients. Medicare paid $60,759 for them.

CMS counts 152 Medicare patients who saw Dr. Nazzal in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 3.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nazzal's median patient age at 73, with 55% women.

In 2024, Dr. Nazzal wrote 2,256 Medicare Part D claims for 202 patients. 85% of them were for generic drugs. CMS names the drug for 1,969 of them, across 46 drugs with 11 or more claims each, at $231,862 in total drug cost. In 2023, CMS named 1,922 claims across 49 drugs.

Dr. Nazzal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nazzal as offering telehealth.

Dmand AI links 8 papers to Dr. Nazzal, published from 2021 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Antineoplastic Agents, Breast Neoplasms and Patient Satisfaction. Dr. Nazzal's most frequent co-authors are Bryan P. Schneider, MD and Meghna S. Trivedi, MD.

CMS Open Payments shows 83 general payments to Dr. Nazzal from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. OPKO Pharmaceuticals, LLC paid the most, $311.